Leukemia Research
Volume 25, Issue 12 , Pages 1099-1105, December 2001

p53 and redox state in etoposide-induced acute myeloblastic leukemia cell death

  • Pirjo Koistinen

      Affiliations

    • Department of Internal Medicine, University of Oulu, Kajaanintie 50, FIN-90220 Oulu, Finland
    • Corresponding Author InformationCorresponding author. Tel.: +358-8-3152011; fax: +358-8-3154139
  • ,
  • Timo Siitonen

      Affiliations

    • Department of Internal Medicine, University of Oulu, Kajaanintie 50, FIN-90220 Oulu, Finland
  • ,
  • Pentti Mäntymaa

      Affiliations

    • Department of Clinical Chemistry, Tampere University Hospital, Tampere, Finland
  • ,
  • Eeva-Riitta Savolainen

      Affiliations

    • Department of Clinical Chemistry, University of Oulu, Kajaanintie 50, FIN-90220 Oulu, Finland

Received 11 September 2000; accepted 10 March 2001.

Abstract 

We investigated whether p53, being a redox-sensitive protein, has a role in the responsiveness of AML cells to etoposide. Two subclones of the OCI/AML-2 cell line, the etoposide-sensitive (ES) and the etoposide-resistant (ER), were used as models. Sensitivity to etoposide was measured by trypan blue and annexin V assays. Etoposide-induced peroxide formation was associated with the induction of cell death. Evident expression of mutated p53 was observed in both subclones in basal growth conditions as analysed by Western blotting and flow cytometry. After etoposide exposure for up to 24 hours, some nuclear accumulation of p53 was observed in the ER subclone, as analysed by Western blotting. The conformation of p53, however, was not changed from mutated toward wild-type during exposure in either of the subclones as analysed by flow cytometry. In conclusion, etoposide-induced change in cellular redox state was associated with apoptosis, but was not a sufficient stimulus for p53 to make its conformation active. Thus, mutated p53 seems to have no role in etoposide-induced apoptosis.

Keywords:  p53, Redox state, Etoposide, Apoptosis, AML

Abbreviations:  MEM, minimal essential medium, AML, acute myeloblastic leukemia, DCHF-DA, dichlorohydrofluorescein-diacetate, ECL, enhanced chemiluminescence, ES, etoposide-sensitive, ER, etoposide-resistant, FBS, fetal bovine serum, FITC, fluorescein-iso-thiocyanate, MnSOD, manganese superoxide dismutase, PARP, poly(ADPribose) polymerase, PBS, phosphate-buffered saline, TBS-T, Tris-buffered saline-Tween

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0145-2126(01)00076-5

Leukemia Research
Volume 25, Issue 12 , Pages 1099-1105, December 2001